|
1 Hills BA, Chen Y, Masters IB et al. Raised bile acid concentrations in SIDS lungs at necropsy. Arch Dis Child.1997; 77: 120-3. 2 Sweet MP, Patti MG, Hoopes C et al. Gastro-oesophageal reflux and aspiration in patients with advanced lung disease. Thorax.2009; 64: 167-73. 3 Nagase T, Uozumi N, Ishii S et al. Acute lung injury by sepsis and acid aspiration: a key role for cytosolic phospholipase A2. Nat Immunol.2000; 1: 42-6. 4 Marik PE. Aspiration pneumonitis and aspiration pneumonia. N Engl J Med.2001; 344: 665-71. 5 Zecca E, Costa S, Lauriola V et al. Bile acid pneumonia: a "new" form of neonatal respiratory distress syndrome? Pediatrics.2004; 114: 269-72. 6 Perng DW, Chang KT, Su KC et al. Exposure of airway epithelium to bile acids associated with gastroesophageal reflux symptoms: a relation to transforming growth factor-beta1 production and fibroblast proliferation. Chest.2007; 132: 1548-56. 7 Wu YC, Hsu PK, Su KC et al. Bile acid aspiration in suspected ventilator-associated pneumonia. Chest.2009; 136: 118-24. 8 Perng DW, Wu YC, Tsai CC et al. Bile acids induce CCN2 production through p38 MAP kinase activation in human bronchial epithelial cells: a factor contributing to airway fibrosis. Respirology.2008; 13: 983-9. 9 Porembka DT, Kier A, Sehlhorst S et al. The pathophysiologic changes following bile aspiration in a porcine lung model. Chest.1993; 104: 919-24. 10 Matthay MA, Folkesson HG, Clerici C. Lung epithelial fluid transport and the resolution of pulmonary edema. Physiol Rev. 2002; 82: 569-600. 11 Matthay MA, Clerici C, Saumon G. Invited review: Active fluid clearance from the distal air spaces of the lung. J Appl Physiol.2002; 93: 1533-41. 12 Ware LB, Matthay MA. The acute respiratory distress syndrome. N Engl J Med.2000; 342: 1334-49. 13 Terao Y, Nakamura T, Morooka H et al. Effect of cyclooxygenase-2 inhibitor pretreatment on gas exchange after hydrochloric acid aspiration in rats. J Anesth.2005; 19: 257-9. 14 Perng DW, Wu YC, Tsai MC et al. Neutrophil elastase stimulates human airway epithelial cells to produce PGE2 through activation of p44/42 MAPK and upregulation of cyclooxygenase-2. Am J Physiol Lung Cell Mol Physiol. 2003; 285: L925-30. 15 Tilley SL, Coffman TM, Koller BH. Mixed messages: modulation of inflammation and immune responses by prostaglandins and thromboxanes. J Clin Invest.2001; 108: 15-23. 16 Vancheri C, Mastruzzo C, Sortino MA et al. The lung as a privileged site for the beneficial actions of PGE2. Trends Immunol.2004; 25: 40-6. 17 Montuschi P, Kharitonov SA, Ciabattoni G et al.Exhaled leukotrienes and prostaglandins in COPD. Thorax. 2003; 58: 585-8. 18 Tai HY, Tam MF, Chou H et al. Pen ch 13 allergen induces secretion of mediators and degradation of ccludin protein of human lung epithelial cells. Allergy.2006; 61: 382-8. 19 N'Guessan PD, Hippenstiel S, Etouem MO et al. Streptococcus pneumoniae induced p38 MAPK- and NF-kappaB-dependent COX-2 expression in human lung epithelium. Am J Physiol Lung Cell Mol Physiol. 2006; 290: L1131-8. 20 Tsukita S, Furuse M, Itoh M. Multifunctional strands in tight junctions. Nat Rev Mol Cell Biol.2001; 2: 285-93. 21 Van Itallie CM, Anderson JM. Claudins and epithelial paracellular transport. Annu Rev Physiol. 2006; 68: 403-29. 22 Cereijido M, Contreras RG, Shoshani L et al. Tight junction and polarity interaction in the transporting epithelial phenotype. Biochim Biophys Acta. 2008; 1778: 770-93. 23 Kypta R, Bernfield M, Burridge K et al. Cell Junctions, Cell Adhesion, and the Extracellular Matrix In: Alberts B, Johnson A, Lewis J, et al., (eds.) Molecular Biology of the Cell. Fourth edition ed. Garland Science, New York,2002; 1065-127. 24 Gumbiner B, Simons K. A functional assay for proteins involved in establishing an epithelial occluding barrier: identification of a uvomorulin-like polypeptide. J Cell Biol.1986; 102: 457-68. 25 Harhaj NS, Antonetti DA. Regulation of tight junctions and loss of barrier function in pathophysiology. Int J Biochem Cell Biol.2004; 36: 1206-37. 26 Fink MP, Delude RL. Epithelial barrier dysfunction: a unifying theme to explain the pathogenesis of multiple organ dysfunction at the cellular level. Crit Care Clin.2005; 21: 177-96. 27 Flores-Benitez D, Rincon-Heredia R, Razgado LF et al. Control of tight junctional sealing: roles of epidermal growth factor and prostaglandin E2. Am J Physiol Cell Physiol. 2009; 297: C611-20. 28 Tanaka MN, Diaz BL, de Souza W et al. Prostaglandin E2-EP1 and EP2 receptor signaling promotes apical junctional complex disassembly of Caco-2 human colorectal cancer cells. BMC Cell Biol. 2008; 9: 63. 29 Raimondi F, Santoro P, Barone MV et al. Bile acids modulate tight junction structure and barrier function of Caco-2 monolayers via EGFR activation. Am J Physiol Gastrointest Liver Physiol. 2008; 294: G906-13. 30 Han B, Mura M, Andrade CF et al. TNFalpha-induced long pentraxin PTX3 expression in human lung epithelial cells via JNK. J Immunol.2005; 175: 8303-11. 31 Perng DW, Wu YC, Chang KT et al. Leukotriene C4 induces TGF-beta1 production in airway epithelium via p38 kinase pathway. Am J Respir Cell Mol Biol.2006; 34: 101-7. 32 Zhang F, Altorki NK, Wu YC et al. Duodenal reflux induces cyclooxygenase-2 in the esophageal mucosa of rats: evidence for involvement of bile acids. Gastroenterology.2001; 121: 1391-9. 33 Borsch-Haubold AG. Regulation of cytosolic phospholipase A2 by phosphorylation. Biochem Soc Trans. 1998; 26: 350-4. 34 Piomelli D. Arachidonic acid in cell signaling. Curr Opin Cell Biol.1993; 5: 274-80. 35 Lin LL, Wartmann M, Lin AY et al. cPLA2 is phosphorylated and activated by MAP kinase. Cell. 1993; 72: 269-78. 36 Letsiou E, Kitsiouli E, Nakos G et al. Mild stretch activates cPLA2 in alveolar type II epithelial cells independently through the MEK/ERK and PI3K pathways. Biochim Biophys Acta. 2011; 1811: 370-6.
|